logo

Valneva Se (VALN)



Trade VALN now with
  Date
  Headline
5/25/2022 1:32:41 AM Valneva Completes Lot-to-Lot Consistency Trial For Single-Shot Chikungunya Vaccine Candidate
5/16/2022 1:41:06 AM Valneva Gets EUA From United Arab Emirates For Inactivated COVID-19 Vaccine, VLA2001
5/16/2022 1:38:47 AM Valneva Gets Notice Of European Commission's Intent To End COVID-19 Vaccine VLA2001 Purchase Deal
4/26/2022 1:55:53 AM Valneva Announces Upsized Financing Arrangement With US Healthcare Funds Deerfield And OrbiMed
4/26/2022 1:54:55 AM Valneva And Pfizer Report Positive Phase 2 Pediatric Data For Lyme Disease Vaccine Candidate, VLA15
3/24/2022 2:05:08 AM Valneva FY Total Revenues EUR 348.1 Mln Vs EUR 110.3 Mln Last Year
3/8/2022 1:04:37 AM Valneva Completes Pivotal Phase 3 Trial Of Single-Shot Chikungunya Vaccine Candidate
2/21/2022 2:00:10 AM Valneva Granted Up To £20 Mln By Scottish Enterprise To Advance Vaccine Development
2/4/2022 1:04:43 AM Valneva, Pfizer Report Further Positive Phase 2 Data For Lyme Disease Vaccine Candidate
2/3/2022 1:13:10 AM Valneva FY Total Revenues EUR 348.1 Mln Vs EUR 110.3 Mln Last Year